July 14, 2011Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and partner Sanofi Aventis (NYSE:SNY) recently announced data from two mid-stage studies of their pipeline candidate sarilumab (REGN88/SAR153191). While one study (MOBILITY) evaluated patients with rheumatoid arthritis (RA) the other (ALIGN) evaluated ankylosing spondylitis (AS) patients. Sarilumab is an antibody targeting the interleukin-6 receptor (IL-6R). The data from the RA trial [...]
Posted in Financial Planning 
No Comments »
July 13, 201107/16/11 Sony and Amazon will launch tablet PC devices in the autumn. Meanwhile, Netflix and Blockbuster are competing for subscribers for their respective DVD by mail services.
Posted in Financial Planning No Comments »
July 13, 2011Chrysler Group LLC, 25% owned by Italy’s Fiat SpA (FIATY), will recall 242,780 units of its top selling truck, Dodge Ram, due to a steering problem leading to a loss of control in the left front wheel. The recalled vehicles include Dodge Ram 1500 Mega Cab 44 vehicles, Dodge Ram 2500 44 trucks, Dodge Ram [...]
Posted in Financial Planning No Comments »
July 13, 2011We have lowered our long-term recommendation on Charles Schwab Corp. (NASDAQ:SCHW) to “Underperform” from “Neutral” based on continuous pressure on its net interest margin (NIM) due to a low interest rate environment. Low interest rate environment continues to be a drag on Schwab’s revenue as the company is highly sensitive to interest rates. Hence, until [...]
Posted in Financial Planning No Comments »
July 13, 2011USD/JPY (4-hour chart) as of Thursday (7/14/2011) has entered into a consolidation after having broken down decisively below the key 79.50 previous support region (now resistance). The breakdown below 79.50, which was the region of the significant May low, was also a breakdown below the 161.8% Fibonacci extension of the last major bullish correction, and [...]
Posted in Financial Planning No Comments »